These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 29736708)

  • 1. Phenotypic Screening of Small Molecules with Antimalarial Activity for Three Different Parasitic Life Stages.
    Kato N; March S; Bhatia SN; Marti M
    Methods Mol Biol; 2018; 1787():41-52. PubMed ID: 29736708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic Screens in Antimalarial Drug Discovery.
    Hovlid ML; Winzeler EA
    Trends Parasitol; 2016 Sep; 32(9):697-707. PubMed ID: 27247245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progressing the global antimalarial portfolio: finding drugs which target multiple Plasmodium life stages.
    Smith PW; Diagana TT; Yeung BK
    Parasitology; 2014 Jan; 141(1):66-76. PubMed ID: 23746048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiapicoplast and gametocytocidal screening to identify the mechanisms of action of compounds within the malaria box.
    Bowman JD; Merino EF; Brooks CF; Striepen B; Carlier PR; Cassera MB
    Antimicrob Agents Chemother; 2014; 58(2):811-9. PubMed ID: 24247137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Luciferase-Based, High-Throughput Assay for Screening and Profiling Transmission-Blocking Compounds against Plasmodium falciparum Gametocytes.
    Lucantoni L; Fidock DA; Avery VM
    Antimicrob Agents Chemother; 2016 Apr; 60(4):2097-107. PubMed ID: 26787698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probing the Open Global Health Chemical Diversity Library for Multistage-Active Starting Points for Next-Generation Antimalarials.
    Abraham M; Gagaring K; Martino ML; Vanaerschot M; Plouffe DM; Calla J; Godinez-Macias KP; Du AY; Wree M; Antonova-Koch Y; Eribez K; Luth MR; Ottilie S; Fidock DA; McNamara CW; Winzeler EA
    ACS Infect Dis; 2020 Apr; 6(4):613-628. PubMed ID: 32078764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolomic Profiling of the Malaria Box Reveals Antimalarial Target Pathways.
    Allman EL; Painter HJ; Samra J; Carrasquilla M; Llinás M
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6635-6649. PubMed ID: 27572391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small-molecule xenomycins inhibit all stages of the Plasmodium life cycle.
    Erath J; Gallego-Delgado J; Xu W; Andriani G; Tanghe S; Gurova KV; Gudkov A; Purmal A; Rydkina E; Rodriguez A
    Antimicrob Agents Chemother; 2015 Mar; 59(3):1427-34. PubMed ID: 25512429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging of Plasmodium liver stages to drive next-generation antimalarial drug discovery.
    Meister S; Plouffe DM; Kuhen KL; Bonamy GM; Wu T; Barnes SW; Bopp SE; Borboa R; Bright AT; Che J; Cohen S; Dharia NV; Gagaring K; Gettayacamin M; Gordon P; Groessl T; Kato N; Lee MC; McNamara CW; Fidock DA; Nagle A; Nam TG; Richmond W; Roland J; Rottmann M; Zhou B; Froissard P; Glynne RJ; Mazier D; Sattabongkot J; Schultz PG; Tuntland T; Walker JR; Zhou Y; Chatterjee A; Diagana TT; Winzeler EA
    Science; 2011 Dec; 334(6061):1372-7. PubMed ID: 22096101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the liver stage of malaria parasites: a yet unmet goal.
    Rodrigues T; Prudêncio M; Moreira R; Mota MM; Lopes F
    J Med Chem; 2012 Feb; 55(3):995-1012. PubMed ID: 22122518
    [No Abstract]   [Full Text] [Related]  

  • 11. The antimalarial resistome - finding new drug targets and their modes of action.
    Carolino K; Winzeler EA
    Curr Opin Microbiol; 2020 Oct; 57():49-55. PubMed ID: 32682267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 4-Nitro styrylquinoline is an antimalarial inhibiting multiple stages of Plasmodium falciparum asexual life cycle.
    Roberts BF; Zheng Y; Cleaveleand J; Lee S; Lee E; Ayong L; Yuan Y; Chakrabarti D
    Int J Parasitol Drugs Drug Resist; 2017 Apr; 7(1):120-129. PubMed ID: 28285258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A New Set of Chemical Starting Points with Plasmodium falciparum Transmission-Blocking Potential for Antimalarial Drug Discovery.
    Almela MJ; Lozano S; Lelièvre J; Colmenarejo G; Coterón JM; Rodrigues J; Gonzalez C; Herreros E
    PLoS One; 2015; 10(8):e0135139. PubMed ID: 26317851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysine acetylation in sexual stage malaria parasites is a target for antimalarial small molecules.
    Trenholme K; Marek L; Duffy S; Pradel G; Fisher G; Hansen FK; Skinner-Adams TS; Butterworth A; Ngwa CJ; Moecking J; Goodman CD; McFadden GI; Sumanadasa SD; Fairlie DP; Avery VM; Kurz T; Andrews KT
    Antimicrob Agents Chemother; 2014 Jul; 58(7):3666-78. PubMed ID: 24733477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel antimalarial chloroquine- and primaquine-quinoxaline 1,4-di-N-oxide hybrids: Design, synthesis, Plasmodium life cycle stage profile, and preliminary toxicity studies.
    Bonilla-Ramirez L; Rios A; Quiliano M; Ramirez-Calderon G; Beltrán-Hortelano I; Franetich JF; Corcuera L; Bordessoulles M; Vettorazzi A; López de Cerain A; Aldana I; Mazier D; Pabón A; Galiano S
    Eur J Med Chem; 2018 Oct; 158():68-81. PubMed ID: 30199706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A male and female gametocyte functional viability assay to identify biologically relevant malaria transmission-blocking drugs.
    Ruecker A; Mathias DK; Straschil U; Churcher TS; Dinglasan RR; Leroy D; Sinden RE; Delves MJ
    Antimicrob Agents Chemother; 2014 Dec; 58(12):7292-302. PubMed ID: 25267664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel multiple-stage antimalarial agent that inhibits protein synthesis.
    Baragaña B; Hallyburton I; Lee MC; Norcross NR; Grimaldi R; Otto TD; Proto WR; Blagborough AM; Meister S; Wirjanata G; Ruecker A; Upton LM; Abraham TS; Almeida MJ; Pradhan A; Porzelle A; Luksch T; Martínez MS; Luksch T; Bolscher JM; Woodland A; Norval S; Zuccotto F; Thomas J; Simeons F; Stojanovski L; Osuna-Cabello M; Brock PM; Churcher TS; Sala KA; Zakutansky SE; Jiménez-Díaz MB; Sanz LM; Riley J; Basak R; Campbell M; Avery VM; Sauerwein RW; Dechering KJ; Noviyanti R; Campo B; Frearson JA; Angulo-Barturen I; Ferrer-Bazaga S; Gamo FJ; Wyatt PG; Leroy D; Siegl P; Delves MJ; Kyle DE; Wittlin S; Marfurt J; Price RN; Sinden RE; Winzeler EA; Charman SA; Bebrevska L; Gray DW; Campbell S; Fairlamb AH; Willis PA; Rayner JC; Fidock DA; Read KD; Gilbert IH
    Nature; 2015 Jun; 522(7556):315-20. PubMed ID: 26085270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probing the Azaaurone Scaffold against the Hepatic and Erythrocytic Stages of Malaria Parasites.
    Carrasco MP; Machado M; Gonçalves L; Sharma M; Gut J; Lukens AK; Wirth DF; André V; Duarte MT; Guedes RC; Dos Santos DJ; Rosenthal PJ; Mazitschek R; Prudêncio M; Moreira R
    ChemMedChem; 2016 Oct; 11(19):2194-2204. PubMed ID: 27538856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multistage and transmission-blocking targeted antimalarials discovered from the open-source MMV Pandemic Response Box.
    Reader J; van der Watt ME; Taylor D; Le Manach C; Mittal N; Ottilie S; Theron A; Moyo P; Erlank E; Nardini L; Venter N; Lauterbach S; Bezuidenhout B; Horatscheck A; van Heerden A; Spillman NJ; Cowell AN; Connacher J; Opperman D; Orchard LM; Llinás M; Istvan ES; Goldberg DE; Boyle GA; Calvo D; Mancama D; Coetzer TL; Winzeler EA; Duffy J; Koekemoer LL; Basarab G; Chibale K; Birkholtz LM
    Nat Commun; 2021 Jan; 12(1):269. PubMed ID: 33431834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insights into Integrated Lead Generation and Target Identification in Malaria and Tuberculosis Drug Discovery.
    Okombo J; Chibale K
    Acc Chem Res; 2017 Jul; 50(7):1606-1616. PubMed ID: 28636311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.